BioPharmX Corp., a leading pharmaceutical company developing and promoting health products for the dermatology and women’s market, revealed it has completed the “last subject visit in its Phase 2b trial,” as of March. Read More »

DelMar Pharmaceuticals Inc., a company fighting for cancer patients and therapies, decreased its public stock aggregate share from 2.77 million to 2.08 million this month. Read More »

Amgen and Novartis are working together to fight against migraines with erenumab, an expanded commercial collaboration building on a global neuroscience collaboration in Alzheimer's disease and migraine established in 2015. Read More »

Teva Pharmaceutical Industries Ltd. has launched AirDuo RespiClick, an inhalation powder for the treatment of asthma in patients 12 and older. Read More »

To make health care more affordable for those who need it, Kmart Pharmacy is reducing the price of epinephrine auto-injector pens. Read More »

Josie Martin has been named vice president of corporate affairs and communications for Purdue Pharma LP. Read More »

The Corporate Whistleblower Center is encouraging individuals to reach out to authorities if they know of unsanitary pharmacy practices. Read More »

The Pharmaceutical Care Management Association is beginning the DrugBenefitSolutions national campaign, in which it seeks to explain how pharmacy benefits managers are helping to reduce the price of medications and assist consumers, as well as employers and unions. Read More »

Biologics Inc., a McKesson Specialty Health oncology pharmacy services company, has been chosen by Tesaro Inc. to provide its new drug. Read More »

Purdue Pharma LP's Carrie Chomiak will be stepping up into a substantial business role as lead of over-the-counter product franchise for brands including Betadine microbicide antiseptics, Slow-Mag magnesium chloride supplements, Senokot laxative and Colace stool softener. Read More »

Shire PLC has published results from its Phase 1b lanadelumab study in the New England Journal of Medicine. Read More »

CVS Health recently opened a MinuteClinic walk-in medical clinic inside the CVS Pharmacy store on K Street NW in Washington D.C. Read More »

Allergan recently announced a new campaign to raise awareness for Chronic Dry Eye, using the slogan “before we had our voice, we had eyes.” Read More »

Allergan will sponsor the Alzheimer's Foundation of America's (AFA) "15th Anniversary National Educating America Tour” that honors AFA’s 15 years of Alzheimer’s education. Read More »

ArQule Inc. and Daiichi Sankyo's METIV-HCC Phase 3 study of tivantinib in hepatocellular carcinoma failed to meet its primary endpoint of improving overall survival. Read More »

The Global Initiative for Asthma’s report, Global Strategy for Asthma Management and Prevention, is recommending allergy immunotherapy as a treatment option. Read More »

Genentech's Phase II Mmotion150 study for Tecentriq compared Tecentriq plus Avastin and Tecentriq monotherapy to sunitinib alone reinforced the potential of the combination drug for the treatment of patients with previously untreated, locally advanced or metastatic renal cell carcinoma. Read More »

Albertson’s Cos. have trained close to 3,000 pharmacists in administering naloxone to treat patients overdosing on opioids. Read More »

GlaxoSmithKline (GSK) and Innoviva Inc. recently released positive results for a study evaluating Relvar Ellipta in treating asthma. Read More »

Shire PLC's Natpar, an adjunctive treatment for adult patients with chronic hypoparathyroidism, was reviewed positively by the Committee for Medicinal Products for Human Use of the European Medicines Agency. Read More »